Showing results (21-30 of 102) with videos related to
Sort By:
Pageof 11
Pharmaceuticals (Basel, Switzerland)|July 28, 2026
Preclinical Evaluation of Dual NOP/Mu Partial Agonists for Methamphetamine Use DisorderThamires Righi, Gilles Zribi, Sebastian Garcia, et al.Journal of Medicinal Chemistry|September 29, 2006
Structural determinants of opioid activity in derivatives of 14-aminomorphinones: effects of changes to the chain linking of the C14-amino group to the aryl ringDavid Rennison, Humphrey Moynihan, John R Traynor, et al.British Journal of Pharmacology|October 3, 2017
Antidepressant-like effects of BU10119, a novel buprenorphine analogue with mixed κ/μ receptor antagonist properties, in miceAbdulrahman Almatroudi, Mehrnoosh Ostovar, Christopher P Bailey, et al.Journal of Medicinal Chemistry|August 27, 2011
Structural determinants of opioid and NOP receptor activity in derivatives of buprenorphineGerta Cami-Kobeci, Willma E Polgar, Taline V Khroyan, et al.Journal of Medicinal Chemistry|January 10, 2003
The role of the side chain in determining relative delta- and kappa-affinity in C5'-substituted analogues of naltrindoleShannon L Black, Andrew R Jales, Wolfgang Brandt, et al.Chemistry & Biodiversity|July 20, 2007
Isolation and chemical modification of clerodane diterpenoids from Salvia species as potential agonists at the kappa-opioid receptorYiqiang Li, Stephen M Husbands, Mary F Mahon, et al.Biochemistry|February 19, 2011
A nanomolar-potency small molecule inhibitor of regulator of G-protein signaling proteinsLevi L Blazer, Haoming Zhang, Emma M Casey, et al.Journal of Medicinal Chemistry|April 4, 2003
14-amino, 14-alkylamino, and 14-acylamino analogs of oxymorphindole. Differential effects on opioid receptor binding and functional profilesPeter Grundt, Andrew R Jales, John R Traynor, et al.European Journal of Pharmacology|May 14, 2003
Behavioral effects of rimcazole analogues alone and in combination with cocaineJonathan L Katz, Therissa A Libby, Theresa Kopajtic, et al.Neuropharmacology|April 4, 2022
PPL-138 (BU10038): A bifunctional NOP/mu partial agonist that reduces cocaine self-administration in ratsAndrea Cippitelli, Madeline Martinez, Gilles Zribi, et al.Pageof 11